Lucas Elena has Announced the Creation of Eyenostics SAS
Eyenostics is a Contract Research Organization (CRO) dedicated to research and analysis of ocular biomarkers for clinical and preclinical studies using Flow Cytometry and RT-qPCR methods. With its experienced team of employees, partners and a renowned consultant, Eyenostics’ ambition is to become a preferred business partner for big pharmaceutical companies and biotechnology companies looking for new, relevant data for their ophthalmology studies.
Eyenostics’ strength lies in the vast experience of its CSO, Dr. F. Brignole, who has been known for more than 20 years for her work on Ocular Biomarkers. Recently, Eyenostics successfully transferred her HLA-DR analysis method by Flow Cytometry.
Eyenostics is currently working on one US clinical study and two European clinical studies, and has already analyzed more than 450 samples.
Prof. Baudouin says about Eyenostics, ”Since 1992, when I found that the ocular surface shows elevated levels of inflammation in dry eyes, the development of new techniques for measuring inflammation and exploring potential biomarkers for ocular surface diseases has become a very attractive challenge. HLA-DR appeared to be one of the most reliable markers, and with the technique using flow cytometry developed by my team in the late 90’s, it has been successfully and repeatedly used in several multicenter trials investigating immunomodulating strategies for dry eye. The new CRO, Eyenostics, has very strong, promising capabilities. It is a step forward from innovative academic research to a highly valuable GCLP platform accessible to everyone seeking to explore inflammation in ocular surface diseases, and notably for investigating the efficacy of new drugs, with the advantage of supporting clinical data with reliable surrogate markers.”
Lucas Elena, Eyenostics’ President, will participate in:
-TFOS conference, 7-10 September 2016 in Montpelier France
-5èmes Rencontres OPHTA BIOTECH, September 30th 2016 in Cannes France
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SEOUL-SEMICONDUCTOR23.3.2018 19:30 | pressemeddelelse
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine
ELLIOTT-MANAGEMENT-CORP23.3.2018 17:07 | pressemeddelelse
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:54 | pressemeddelelse
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:52 | pressemeddelelse
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets
JANSSEN23.3.2018 13:48 | pressemeddelelse
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)
AITHEON23.3.2018 13:02 | pressemeddelelse
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum